Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 10, 2021, titled "Sun Pharma signs voluntary licensing agreement with Eli Lilly for expanding access to Baricitinib to help alleviate the burden of Covid-19 in India".